Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Change in Inventory (2020 - 2025)

Historic Change in Inventory for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $4.0 million.

  • RxSight's Change in Inventory rose 6506.68% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 16801.73%. This contributed to the annual value of $5.0 million for FY2024, which is 8162.97% up from last year.
  • Per RxSight's latest filing, its Change in Inventory stood at $4.0 million for Q3 2025, which was up 6506.68% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, RxSight's Change in Inventory ranged from a high of $4.0 million in Q3 2022 and a low of -$1.4 million during Q4 2021
  • Its 5-year average for Change in Inventory is $1.4 million, with a median of $1.4 million in 2024.
  • In the last 5 years, RxSight's Change in Inventory surged by 528214.29% in 2021 and then tumbled by 56600.99% in 2023.
  • Over the past 5 years, RxSight's Change in Inventory (Quarter) stood at -$1.4 million in 2021, then surged by 85.5% to -$203000.0 in 2022, then tumbled by 566.01% to -$1.4 million in 2023, then soared by 130.18% to $408000.0 in 2024, then soared by 869.36% to $4.0 million in 2025.
  • Its last three reported values are $4.0 million in Q3 2025, $2.7 million for Q2 2025, and $1.6 million during Q1 2025.